Association of smoking, sleep apnea, and plasma alkalosis with nocturnal ventricular arrhythmias in men with systolic heart failure

Chest

Volumn 141, Issue 6, 2012, Pages 1449-1456

  Javaheri, Shahrokh ^a,b   Shukla, Rakesh ^a   Wexler, Laura ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ALKALOSIS; APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BLOOD PH; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURNAL HEART VENTRICLE ARRHYTHMIA; PLASMA ALKALINITY; PLASMA ALKALOSIS; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SMOKING; SUDDEN DEATH; SYSTOLIC HEART FAILURE;

EID: 84862023926     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1724     Document Type: Article

References (55)

1. Verrier RL, Josephson ME. Impact of sleep on arrhythmogenesis. Circ Arrhythm Electrophysiol. 2009;2(4):450-459.
2. Carson PA, O'Connor CM, Miller AB, et al. Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial. J Am Coll Cardiol. 2000;36(2):541-546.
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991; 325(5):293-302.
4. Poole-Wilson PA, Swedberg K, Cleland JGF, et al Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13. (Pubitemid 36835815)
5. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease. An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-1111.
6. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154-2159. (Pubitemid 28262123)
7. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation. 2003;107(5):727-732. (Pubitemid 36222601)
8. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9(3):251-257. (Pubitemid 46335886)
9. Arzt M, Floras JS, Logan AG, et al CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25):3173-3180. (Pubitemid 47012231)
10. Corrà U, Pistono M, Mezzani A, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113(1):44-50. (Pubitemid 43958487)
11. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99(11):1435-1440. (Pubitemid 29140908)
12. Javaheri S, Shukla R, Zeigler H, Wexler LF. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49(20):2028-2034. (Pubitemid 46734642)
13. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005;352(12):1206-1214.
14. Mehra R, Benjamin EJ, Shahar E, et al Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173(8):910-916.
15. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52(5):490-494. (Pubitemid 13049175)
16. Alonso-Fernández A, García-Río F, Racionero MA, et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest. 2005;127(1):15-22. (Pubitemid 41724550)
17. Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance. Am J Med. 1982;73(3):317-321. (Pubitemid 12031779)
18. Monahan K, Storfer-Isser A, Mehra R, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol. 2009;54(19):1797-1804.
19. Davies SW, John LM, Wedzicha JA, Lipkin DP. Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation. Br Heart J. 1991;65(2):77-83.
20. Cripps T, Rocker G, Stradling J. Nocturnal hypoxia and arrhythmias in patients with impaired left ventricular function. Br Heart J. 1992;68(4):382-386.
21. Serizawa N, Yumino D, Kajimoto K, et al. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverterdefibrillator. Am J Cardiol. 2008;102(8):1064-1068.
22. Bitter T, Westerheide N, Prinz C, et al. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J. 2011;32(1):61-74.
23. Staniforth AD, Sporton SC, Early MJ, Wedzicha JA, Nathan AW, Schilling RJ. Ventricular arrhythmia, Cheyne-Stokes respiration, and death: observations from patients with defibrillators. Heart. 2005;91(11):1418-1422. (Pubitemid 41531812)
24. Goldenberg I, Moss AJ, McNitt S, et al Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006;17(9):931-936.
25. Goldenberg I, Jonas M, Tenenbaum A, et al Bezafibrate Infarction Prevention Study Group. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med. 2003;163(19):2301-2305. (Pubitemid 37310190)
26. Bonnet M, Carley D, Carskadon M, et al. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep. 1992;15(2):174-184.
27. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106(1):21-28. (Pubitemid 41728905)
28. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353(9169):2001-2007.
29. Packer M, Coats AJ, Fowler MB, et al Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344(22):1651-1658. (Pubitemid 32479962)
30. van de Borne P, Oren R, Abouassaly C, Anderson E, Somers VK. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;81(4):432-436. (Pubitemid 28099533)
31. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152(2):473-479.
32. Usui K, Bradley TD, Spaak J, et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol. 2005;45(12):2008-2011. (Pubitemid 40814123)
33. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation. 1998;98(8):772-776. (Pubitemid 28391842)
34. Javaheri S. Effect of continuous positive airway pressure of sleep apnea and ventricular irritability in patients with heart failure. Circulation. 2000;101(4):391-397.
35. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax. 2005;60(9):781-785. (Pubitemid 41297899)
36. Morgan BJ, Crabtree DC, Puleo DS, Badr MS, Toiber F, Skatrud JB. Neurocirculatory consequences of abrupt change in sleep state in humans. J Appl Physiol. 1996; 80(5):1627-1636. (Pubitemid 26143913)
37. Schneider H, Schaub CD, Chen CA, et al. Effects of arousal and sleep state on systemic and pulmonary hemodynamics in obstructive apnea. J Appl Physiol. 2000;88(3):1084-1092. (Pubitemid 30154915)
38. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol. 1989;67(5):2101-2106. (Pubitemid 20039424)
39. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87(1):76-79. (Pubitemid 23019336)
40. Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;37(6):1677-1682.
41. Peters RW, Brooks MM, Todd L, Liebson PR, Wilhelmsen L; The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Smoking cessation and arrhythmic death: the CAST experience. J Am Coll Cardiol. 1995;26(5):1287-1292.
42. Ayres SM, Grace WJ. Inappropriate ventilation and hypoxemia as causes of cardiac arrhythmias. The control of arrhythmias without antiarrhythmic drugs. Am J Med. 1969;46(4):495-505.
43. Gennari FJ, Kassirer JP. Respiratory alkalosis. In: Cohen JJ, Kassirer JP, eds. Acid-Base. Boston, MA: Little, Brown; 1982:349-376.
44. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol. 1989;67(5):2095-2100. (Pubitemid 20039423)
45. Stäubli M, Rohner F, Kammer P, Ziegler W, Straub PW. Plasma volume and proteins in voluntary hyperventilation. J Appl Physiol. 1986;60(5):1549- 1553. (Pubitemid 16088041)
46. Krapf R, Caduff P, Wagdi P, Stäubli M, Hulter HN. Plasma potassium response to acute respiratory alkalosis. Kidney Int. 1995;47(1):217-224.
47. Mitchell JH, Wildenthal K, Johnson RL Jr. The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int. 1972;1(5):375-389.
48. 2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med. 1998;128(3):204-207.
49. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JS. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med. 2002;165(9):1251-1260.
50. Zannad F, McMurray JJV, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Eng J Med. 2011;364(1):11-21.
51. Dahlstrom U, Hakansson J, Swedberg K, Waldenstrom A. Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden. Eur J Heart Fail. 2009;11(1):92-98.
52. Calvert MJ, Shankar A, McManus RJ, Ryan R, Freemantle N. Evaluation of the management of heart failure in primary care. Fam Pract. 2009;26(2):145-153.
53. Ryan CM, Floras JS, Logan AG, et al CANPAP Investigators. Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J. 2010;35(3):592-597.
54. Chiu K-L, Ryan CM, Shiota S, et al. Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med. 2006;174(12):1378-1383. (Pubitemid 44913040)
55. Verrier RL, Mittleman MA. Sleep-related cardiac risk. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier; 2010:1161-1170.